Evidence map›Paper›PMID 28898996›Full record

ArticleCardiovascular research2017

The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability.

Giulia Campostrini, Mattia Bonzanni, Alessio Lissoni, Claudia Bazzini, Raffaella Milanesi, Elena Vezzoli, Maura Francolini, Mirko Baruscotti, Annalisa Bucchi, Ilaria Rivolta and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Emerging Regulatory Mechanisms in Sinoatrial Node Automaticity.Journal of cellular and molecular medicine · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Giulia CampostriniDepartment of Biosciences, The PaceLab, Università degli Studi di Milano, Milano, Italy.
Mattia BonzanniDepartment of Biosciences, The PaceLab, Università degli Studi di Milano, Milano, Italy.
Alessio LissoniDepartment of Biosciences, The PaceLab, Università degli Studi di Milano, Milano, Italy.
Claudia BazziniDepartment of Biosciences, The PaceLab, Università degli Studi di Milano, Milano, Italy.
Raffaella MilanesiDepartment of Biosciences, The PaceLab, Università degli Studi di Milano, Milano, Italy.
Elena VezzoliDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milano, Italy.
Maura FrancoliniDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milano, Italy.
Mirko BaruscottiDepartment of Biosciences, The PaceLab, Università degli Studi di Milano, Milano, Italy.
Annalisa BucchiDepartment of Biosciences, The PaceLab, Università degli Studi di Milano, Milano, Italy.
Ilaria RivoltaDepartment of Health Science, Università di Milano Bicocca, Monza, Italy.
Matteo FantiniCellular and Molecular Engineering Laboratory 'S. Cavalcanti', Department of Electrical, Electronic and Information Engineering 'Guglielmo Marconi', University of Bologna, Bologna, Italy.
Stefano SeveriCellular and Molecular Engineering Laboratory 'S. Cavalcanti', Department of Electrical, Electronic and Information Engineering 'Guglielmo Marconi', University of Bologna, Bologna, Italy.
Riccardo CappatoArrhythmia & Electrophysiology Unit II, Humanitas Gavazzeni Clinics, Bergamo, Italy.
Lia CrottiCenter for Cardiac Arrhythmias of Genetic Origin, IRCCS Istituto Auxologico Italiano, Milano, Italy.
Peter J SchwartzCenter for Cardiac Arrhythmias of Genetic Origin, IRCCS Istituto Auxologico Italiano, Milano, Italy.
Dario DiFrancescoDepartment of Biosciences, The PaceLab, Università degli Studi di Milano, Milano, Italy.
Andrea BarbutiDepartment of Biosciences, The PaceLab, Università degli Studi di Milano, Milano, Italy.
University of Milan · ITIRCCS Humanitas Research Hospital · ITIRCCS Istituto Auxologico Italiano · ITLaboratori Guglielmo Marconi (Italy) · ITUniversity of Bologna · ITUniversity of Milano-Bicocca · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsCaveolinopathies are a family of genetic disorders arising from alterations of the caveolin-3 (cav-3) gene. The T78M cav-3 variant has been associated with both skeletal and cardiac muscle pathologies but its functional contribution, especially to cardiac diseases, is still controversial. Here, we evaluated the effect of the T78M cav-3 variant on cardiac ion channel function and membrane excitability. METHODS AND

resultsWe transfected either the wild type (WT) or T78M cav-3 in caveolin-1 knock-out mouse embryonic fibroblasts and found by immunofluorescence and electron microscopy that both are expressed at the plasma membrane and form caveolae. Two ion channels known to interact and co-immunoprecipitate with the cav-3, hKv1.5 and hHCN4, interact also with T78M cav-3 and reside in lipid rafts. Electrophysiological analysis showed that the T78M cav-3 causes hKv1.5 channels to activate and inactivate at more hyperpolarized potentials and the hHCN4 channels to activate at more depolarized potentials, in a dominant way. In spontaneously beating neonatal cardiomyocytes, the expression of the T78M cav-3 significantly increased action potential peak-to-peak variability without altering neither the mean rate nor the maximum diastolic potential. We also found that in a small cohort of patients with supraventricular arrhythmias, the T78M cav-3 variant is more frequent than in the general population. Finally, in silico analysis of both sinoatrial and atrial cell models confirmed that the T78M-dependent changes are compatible with a pro-arrhythmic effect.

conclusionThis study demonstrates that the T78M cav-3 induces complex modifications in ion channel function that ultimately alter membrane excitability. The presence of the T78M cav-3 can thus generate a susceptible substrate that, in concert with other structural alterations and/or genetic mutations, may become arrhythmogenic.

Indexed as

Action PotentialsMutation3T3 CellsAnimalsArrhythmias, CardiacCaveolaeCaveolin 1Caveolin 3Computer SimulationFibroblastsHeart RateHumansHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIon Channel GatingKineticsKv1.5 Potassium ChannelCav1 protein, mouseCAV3 protein, humanCaveolin 1Caveolin 3HCN4 protein, humanHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsKCNA5 protein, humanKv1.5 Potassium ChannelMuscle ProteinsPotassium ChannelsArrhythmiaCaveolinElectrophysiologyGenetic diseasesIon channels

Identifiers

PMID28898996
PMCPMC5852518
OpenAlexW2636798031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.